Donovan HS - Search Results

1

Sexual Health as Part of Gynecologic Cancer Care: What Do Patients Want?

Hay CM, Donovan HS, Hartnett EG, Carter J, Roberge MC, Campbell GB, Zuchelkowski BE, Taylor SE. Hay CM, et al. Among authors: donovan hs. Int J Gynecol Cancer. 2018 Nov;28(9):1737-1742. doi: 10.1097/IGC.0000000000001376. Int J Gynecol Cancer. 2018. PMID: 30358703 Free PMC article.

2

Representations of fatigue in women receiving chemotherapy for gynecologic cancers.

Donovan HS, Ward S. Donovan HS, et al. Oncol Nurs Forum. 2005 Jan 19;32(1):113-6. doi: 10.1188/05.ONF.113-116. Oncol Nurs Forum. 2005. PMID: 15660150

3

Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study.

Friedlander ML, Stockler M, O'Connell R, Voysey M, Oza A, Gillies K, Donovan H, Martyn J, Sjoquist K, Butow P, King MT; Symptom Benefit Study Group. Friedlander ML, et al. Int J Gynecol Cancer. 2014 Jun;24(5):857-64. doi: 10.1097/IGC.0000000000000147. Int J Gynecol Cancer. 2014. PMID: 24844219

4

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

King MT, Stockler MR, Butow P, O'Connell R, Voysey M, Oza AM, Gillies K, Donovan HS, Mercieca-Bebber R, Martyn J, Sjoquist K, Friedlander ML. King MT, et al. Among authors: donovan hs. Int J Gynecol Cancer. 2014 Jun;24(5):865-73. doi: 10.1097/IGC.0000000000000167. Int J Gynecol Cancer. 2014. PMID: 24844220

5

Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer.

Taylor SE, Li R, Petschauer JS, Donovan H, O'Neal S, Keeler AW, Zamboni WC, Edwards RP, Zorn KK. Taylor SE, et al. Gynecol Oncol. 2015 Sep;138(3):548-53. doi: 10.1016/j.ygyno.2015.06.026. Epub 2015 Jun 23. Gynecol Oncol. 2015. PMID: 26111788 Clinical Trial.

6

Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis.

Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC. Donovan HS, et al. Support Care Cancer. 2016 Jun;24(6):2635-42. doi: 10.1007/s00520-015-3071-4. Epub 2016 Jan 8. Support Care Cancer. 2016. PMID: 26746209 Free PMC article.

7

Coping With Pain Severity, Distress, and Consequences in Women With Ovarian Cancer.

Gilbertson-White S, Campbell G, Ward S, Sherwood P, Donovan H. Gilbertson-White S, et al. Cancer Nurs. 2017 Mar/Apr;40(2):117-123. doi: 10.1097/NCC.0000000000000376. Cancer Nurs. 2017. PMID: 27088608 Free PMC article.

8

Application of Text Mining in Cancer Symptom Management.

Lee YJ, Donovan H. Lee YJ, et al. Stud Health Technol Inform. 2016;225:930-1. Stud Health Technol Inform. 2016. PMID: 27332415

9

Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?

Hay CM, Courtney-Brooks M, Lefkowits C, Hagan TL, Edwards RP, Donovan HS. Hay CM, et al. Among authors: donovan hs. Gynecol Oncol. 2016 Nov;143(2):367-370. doi: 10.1016/j.ygyno.2016.08.235. Epub 2016 Aug 13. Gynecol Oncol. 2016. PMID: 27531571 Free PMC article.

10

Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study.

Campbell G, Hagan T, Gilbertson-White S, Houze M, Donovan H. Campbell G, et al. Gynecol Oncol. 2016 Dec;143(3):578-583. doi: 10.1016/j.ygyno.2016.09.013. Epub 2016 Sep 18. Gynecol Oncol. 2016. PMID: 27653982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page